Page last updated: 2024-09-03
rasagiline and dsp 4
rasagiline has been researched along with dsp 4 in 1 studies
Compound Research Comparison
| Studies (rasagiline) | Trials (rasagiline) | Recent Studies (post-2010) (rasagiline) | Studies (dsp 4) | Trials (dsp 4) | Recent Studies (post-2010) (dsp 4) |
|---|---|---|---|---|---|
| 535 | 72 | 314 | 572 | 0 | 80 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Boger, HA; Cantwell, K; Granholm, AC; Hinson, VK; Ledreux, A | 1 |
Other Studies
1 other study(ies) available for rasagiline and dsp 4
| Article | Year |
|---|---|
BDNF levels are increased by aminoindan and rasagiline in a double lesion model of Parkinson׳s disease.
Topics: Animals; Behavior, Animal; Benzylamines; Brain; Brain-Derived Neurotrophic Factor; Chaperonin 60; Cognition; Disease Models, Animal; Dopamine; Indans; Locomotion; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neurons; Neuroprotective Agents; Norepinephrine; Parkinson Disease; Rats; Rats, Inbred F344 | 2016 |